ACI
VIVO

AMP Capital Investors’s Meridian Bioscience Inc VIVO Stock Holding History

AMP Capital Investors’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-30,000
Closed -$289K – 1248
2019
Q4 		$289K Buy
+30,000
New +$282K ﹤0.01% 1073
2016
Q3 		– Sell
-21,305
Closed -$411K – 1288
2016
Q2 		$411K Sell
21,305
-17,827
-46% -$350K ﹤0.01% 986
2016
Q1 		$824K Sell
39,132
-2,519
-6% -$49.6K 0.01% 868
2015
Q4 		$874K Buy
41,651
+20,297
+95% +$389K 0.01% 871
2015
Q3 		$360K Buy
21,354
+4,100
+24% +$74.9K ﹤0.01% 1018
2015
Q2 		$318K Sell
17,254
-12,600
-42% -$234K ﹤0.01% 1037
2015
Q1 		$571K Buy
+29,854
New +$552K ﹤0.01% 989
2014
Q2 		– Sell
-16,454
Closed -$352K – 1267
2014
Q1 		$352K Sell
16,454
-18,346
-53% -$421K ﹤0.01% 1029
2013
Q4 		$926K Sell
34,800
-19,500
-36% -$479K 0.01% 885
2013
Q3 		$1.28M Buy
54,300
+16,900
+45% +$395K 0.01% 799
2013
Q2 		$814K Buy
+37,400
New +$807K 0.01% 963

Other funds holding VIVO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

AMP Capital Investors's VIVO Position: Q1 2020 in Review

AMP Capital Investors sold out of Meridian Bioscience Inc (VIVO) in Q1 2020, closing a stake of 30,000 shares — an estimated $289K sold.

AMP Capital Investors first reported a position in VIVO in Q2 2013 and held it in 11 quarters. The position peaked at $1.28M in Q3 2013. 168 funds tracked by Wall St. Rank hold VIVO as of Q1 2020.

  • AMP Capital Investors reported no remaining Meridian Bioscience Inc position as of Q1 2020 after selling out during the quarter.
  • AMP Capital Investors sold 30,000 Meridian Bioscience Inc shares in Q1 2020, an estimated $289K.
  • AMP Capital Investors first reported a position in Meridian Bioscience Inc in Q2 2013 and held it in 11 quarters.
  • AMP Capital Investors's Meridian Bioscience Inc position peaked at $1.28M in Q3 2013.
  • 168 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2020.

Based on AMP Capital Investors's 13F filing for Q1 2020, filed 13 May 2020.